D12 Ergospirometry (VO₂ max)

Topic

Ergospirometry is a cardiopulmonary exercise test that simultaneously measures oxygen consumption, carbon dioxide production, heart rate, and workload during an incremental exercise protocol, in which the workload increases progressively until the individual reaches their limit of exertion.

By measuring these four variables simultaneously, ergospirometry directly assesses energy balance, identifying three values: maximal oxygen consumption, the anaerobic threshold, and mechanical efficiency.

The first value is maximal oxygen consumption: as the workload increases during the incremental exercise protocol, oxygen consumption also rises until a point is reached where—even if the workload continues to increase—oxygen consumption stops rising; this point represents maximal oxygen consumption and marks the upper limit of the body's capacity to produce energy using oxygen.

The second value is the anaerobic threshold: during the same incremental exercise protocol, a point is reached where carbon dioxide production begins to rise faster than oxygen consumption because the body starts relying on an energy production pathway that no longer requires oxygen to sustain the workload; this point is the anaerobic threshold.

The third value is mechanical efficiency: ergospirometry compares the amount of workload the body produces per unit of oxygen consumed; the less oxygen the body requires to sustain a given workload, the higher the recorded mechanical efficiency.

With maximal oxygen consumption, the anaerobic threshold, and mechanical efficiency identified, ergospirometry distinguishes between two different causes of exercise intolerance: when the anaerobic threshold occurs early and mechanical efficiency drops, the limitation stems from fatigue and metabolic imbalance—specifically, the accumulation of metabolites, the depletion of energy substrates, or a decline in the mechanical efficiency of the muscle itself; Conversely, when peak oxygen consumption is reached before the muscle shows signs of fatigue, the constraint stems from a circulatory limitation to exercise—meaning that tissue perfusion, venous return, or lymphatic drainage fail to deliver sufficient oxygen to the muscle, even though the muscle itself could continue working.

Distinguishing between these two causes is important because they are not addressed in the same way: an intervention targeting fatigue and metabolic imbalance does not correct a circulatory limitation to exercise; meanwhile, ergospirometry—by measuring oxygen consumption, carbon dioxide production, heart rate, and workload within a single incremental exercise protocol—makes it possible to determine which of the two is actually limiting the individual.

ID:626